Adimmune Corp (4142) — Capital Reinvestment Ratio
Adimmune Corp (4142) has a Capital Reinvestment Ratio of 0.06x as of December 2024, meaning it reinvests 0% of its operating cash flow (NT$658.32 Million) in capital expenditures (NT$42.60 Million). Check 4142 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Adimmune Corp Capital Reinvestment Ratio (2007–2024)
This chart tracks Adimmune Corp's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 4142 cash generation efficiency.
Annual Capital Reinvestment Ratio for Adimmune Corp (2007–2024)
Year-by-year Capital Reinvestment Ratio for Adimmune Corp from 2007 to 2024. See how much free cash does Adimmune Corp generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | NT$668.48 Million | NT$155.22 Million | ▲ +147.0% |
| 2020 | 0.09x | NT$2.32 Billion | NT$218.30 Million | ▼ -94.3% |
| 2017 | 1.65x | NT$6.87 Million | NT$11.35 Million | ▲ +36.1% |
| 2010 | 1.21x | NT$516.39 Million | NT$626.30 Million | ▲ +3.5% |
| 2009 | 1.17x | NT$600.42 Million | NT$703.82 Million | ▼ -86.2% |
| 2007 | 8.50x | NT$31.26 Million | NT$265.77 Million | — |